Cardiff Oncology, Inc. - Common Stock (NQ:CRDF)

2.785 -0.025 (-0.89%)

Streaming Delayed Price Updated: 1:42 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cardiff Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

The Week Ahead In Biotech (Jan. 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week ↗

January 16, 2022

Biotech stocks posted losses for the third straight week, as the sector reacted to broader market weakness and announcements out of the 2022 JPMorgan Healthcare conference. Here are the key catalysts...

Via Talk Markets

The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week ↗

January 16, 2022

Biotech stocks posted losses for the third straight week, as the sector reacted to broader market weakness and announcements out of the 2022 JPMorgan Healthcare conference. Swiss...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 07, 2021

Gainers PLx Pharma (NASDAQ:PLXP) stock in...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 26, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 68.43% to $17.18 during Friday's pre-market session. The market value of their outstanding shares is at $119.6...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 ↗

December 08, 2021

Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD...

Via Benzinga

Why Cardiff Oncology Shares Were Up More Than 15% on Thursday ↗

November 18, 2021

The clinical-stage oncology specialist is getting an infusion of cash from pharmaceutical giant Pfizer.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 18, 2021

Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) shares moved upwards by 78.87% to $38.06 during Thursday's regular session. As of 12:30 EST, this security is trading at...

Via Benzinga

54 Biggest Movers From Yesterday ↗

November 19, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

November 18, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the...

Via Benzinga

Cardiff Oncology Stock Rises After $15M Equity Investment From Pfizer ↗

November 18, 2021

Pfizer Inc (NYSE: PFE) has made a $15 million equity investment in Cardiff Oncology Inc (NASDAQ: CRDF) as part of the Pfizer Breakthrough Growth...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 18, 2021

Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) stock increased by 78.28% to $37.94 during Thursday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

Why Shares of Cardiff Oncology Rose on Monday ↗

September 13, 2021

An insider buy and positive data may have boosted optimism.

Via The Motley Fool

35 Stocks Moving In Thursday's Mid-Day Session ↗

September 09, 2021

Gainers Gevo, Inc. (NASDAQ: GEVO) shares climbed 36.6% to $7.91. Chevron and Gevo announced intent to pursue sustainable aviation fuel investment. Offerpad Solutions Inc (NYSE:...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 09, 2021

Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff...

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

21 Stocks Moving in Thursday's Pre-Market Session ↗

September 09, 2021

Gainers Cardiff Oncology, Inc. (NASDAQ: CRDF) rose 17.3% to $8.27 in pre-market trading after the company announced new data from its Phase 1b/2 trial in KRAS-mutated metastatic...

Via Benzinga

Why Are Investors Cheering Cardiff Oncology's New Data In Colorectal Cancer Setting? ↗

September 09, 2021

Cardiff Oncology Inc (NASDAQ: CRDF) has announced new data from Phase 1b/2 evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/bevacizumab...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 08, 2021

Gainers Cardiff Oncology (NASDAQ:

Via Benzinga

The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week ↗

September 05, 2021

Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday...

Via Benzinga

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

21 Stocks Moving in Thursday's Pre-Market Session ↗

July 22, 2021

Gainers PainReform Ltd (NASDAQ: PRFX) shares rose 123% to $7.00 in pre-market trading. Second Sight Medical Products Inc (NASDAQ: EYES) shares rose 29% to $5.57 in pre-market...

Via Benzinga

84 Biggest Movers From Friday ↗

August 09, 2021

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 21, 2021

Gainers Gracell Biotechnologies (NASDAQ:GRCL) shares rose 21.25% to $17.69 during Friday's regular session. Trading volume for Gracell Biotechnologies's stock is...

Via Benzinga

Let's Take A Look At This Weeks Top Performing Sectors 5/5 ↗

May 05, 2021

Investing in different stock sectors allows you to diversify your portfolio through targeted exposure from companies in specific segments of the economy. Utilizing sector-based...

Via Benzinga

Topics Economy

Let's Take A Look At This Weeks Top Performing Sectors 4/28 ↗

April 28, 2021

Using sector-based investment strategies can help you capitalize on changing business cycles. So far this week the Energy Minerals, Finance, Health services, Transportation, and...

Via Benzinga

Cardiff Oncology's Onvansertib Shows Durable Response, Progression-Free Survival In Colorectal Cancer Patients ↗

April 12, 2021

Cardiff Oncology Inc (NASDAQ: CRDF) has announced data from its ongoing Phase 1b/2 trial evaluating onvansertib combined with standard-of-care therapy in...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.